cancer immunotherapy - Providence Business News

Home Tags Cancer immunotherapy

EPIVAX WILL celebrate its 20th anniversary in a new Olneyville office at 166 Valley St. June 15.

EpiVax moves growing staff to Olneyville

Health Services 06/11/2018

PROVIDENCE — Immunology engineering biotech firm EpiVax Inc. continues an eventful anniversary year with a new headquarters at 188 Valley St. in the Rising...

EPIVAX PRESIDENT AND CEO Dr. Anne S. De Groot. EpiVax has launched a venture-backed spinoff, Epivax Oncology. / PBN FILE PHOTO

EpiVax launches EpiVax Oncology for personalized cancer vaccines

Health Services 09/25/2017

PROVIDENCE — Immunolgy engineering biotech firm EpiVax Inc. has launched EpiVax Oncology Inc., a venture-backed spinoff focused on the development of personalized therapeutic cancer...

- Featured Event -

Latest News

Dr. Aurora Pryor named president of Brown Surgical Associates

10/06/2024

Five Questions With: Christina Tortolani

10/06/2024

Lifespan Sickle Cell Program receives $1M grant

10/06/2024

Brown to expand research on substance misuse, chronic disease with $12.3M...

10/06/2024

SEC filing of the week: Avangrid shareholders approve $2.55B takeover bid

10/04/2024

SUBSCRIBE TO

PBN's All Access Subscription

PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.